针对膝关节骨关节炎的向治疗:从基本到临床
Li Chen1, Feng-Lan Huang1, Qi Tang1
1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Medicine
|August 19, 2025
概括
膝关节骨关节炎 (KOA) 治疗正在推进,新的向疗法如生物制剂和纳米医学. 本综述强调了最近的突破,为改善患者的治疗结果和管理这个日益增长的公共卫生挑战提供了希望.
科学领域:
- 整形外科 整形外科 整形外科
- 类风湿病学 类风湿病学
- 再生医学是一种再生医学.
背景情况:
- 由于人口老龄化和生活方式因素,膝关节骨关节炎 (KOA) 发病率正在上升,这对公众健康构成了重大挑战.
- 目前对KOA的治疗方法不足以解决其复杂的病理生理学和多样化的临床表现,突出了未满足的医疗需求.
- 有效的KOA管理对于改善患者的生活质量至关重要.
研究的目的:
- 审查和总结最近在膝关节骨关节炎的有针对性的治疗干预措施的进展.
- 分析药物治疗的最新突破和KOA治疗的临床数据.
- 为寻求有效的KOA管理策略的临床医生和研究人员提供宝贵的资源.
主要方法:
- 关于膝关节骨关节炎的向治疗方法的当前文献的全面审查.
- 对新型KOA治疗方法的临床试验数据的分析,包括生物制剂,纳米医学,基因疗法和细胞疗法.
- 检查药物纳米载体和输送系统的进展,以提高治疗疗效.
主要成果:
- 许多新的向疗法,包括小分子抑制剂,单克隆抗体,基于纳米载体的疗法,基因疗法和细胞疗法,正在对KOA进行临床试验.
- 纳米载体技术的进步显示出改善KOA治疗中治疗剂的疗效的前景.
- 该审查整合了新兴治疗方法的信息,提供了对其潜在临床应用的见解.
结论:
- 向疗法代表了管理膝关节关节炎的前沿前沿,解决了当前治疗选择的局限性.
- 持续的研究和临床试验对于将这些新的治疗方法转化为KOA的有效临床实践至关重要.
- 这些进展为患有膝关节关节炎的个人提供了更好的疾病控制和改善生活质量的希望.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K